NCT03265431View on ClinicalTrials.gov

Evaluation of PET/MR in Patients Selected for Ablation Therapy

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

July 14, 2017

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Arrhythmias, Cardiac

Interventions

DRUG

18F-TPP

Imaging with 18-F-TPP (18F-BFPET)

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER